Arca Biopharma | ABIO - Ingresos Por Ventas





Ventas Cambio Fecha
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 8.62B 1.28B 2026-03
Arca Biopharma 0 0 2025-03
Biogen USD 2.25B 30M 2026-03
Brainstorm Cell Therapeutics 0 0 2025-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Cipla INR 65.41B 9.77B 2026-03
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 6.35M 60.98M 2026-03
CSL USD 8.33B 4.79B 2025-12
Cytokinetics USD 19.35M 1.59M 2026-03
Daiichi Sankyo JPY 587B 28.89B 2026-03
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Grifols EUR 2B 306.7M 2026-03
Laboratory Of America USD 3.54B 20M 2026-03
Myriad Genetics USD 200.4M 9.4M 2026-03
Otsuka Holdings JPY 630.34B 19.81B 2026-03
Pfizer USD 14.5B 3.08B 2026-03
United Therapeutics USD 781.5M 8.7M 2026-03